Talk to your doctor.
A d d i n g
A B I L I F Y
to an antidepressant such as one of these* can help
treat unresolved symptoms of depression.
A pproxim ately 2 out of 3 people being treated fo r depression still have unresolved sym ptom s.
A sk your d o cto r about the option o f ad d in g A B IL IF Y to your current antidepressant.
ABILIFY is FDA-approved to tre a t depression in adults when added to an antidepressant.
* O r g e n e ric e q u iv a le n ts w h e re a v a ila b le .
IMPORTANT SAFETY INFORMATION:
Elderly patients with dementia-related psychosis (eg, an inability to perform daily activities due to increased memory loss)
taking ABILIFY have an increased risk of death or stroke. ABILIFY is not approved for treating these patients.
Antidepressants can increase suicidal thoughts and behaviors in children, teens, and young adults. Serious mental illnesses are
themselves associated with an increase in the risk of suicide. When taking ABILIFY call your doctor right away if you have new
or worsening depression symptoms, unusual changes in behavior, or thoughts of suicide. Patients and their caregivers should
be especially observant within the first few months of treatment or after a change in dose. Approved only for adults 18 and over
with depression.
• Alert your doctor if you develop very high fever, rigid m uscles, shaking, confusion, sweating, or
increased heart rate and blood pressure, as these may be signs of a rare but potentially fatal
condition called neuroleptic malignant syndrome (NMS)
• If you develop abnormal or uncontrollable facial movements, notify your doctor, as these may
be signs of tardive dyskinesia (TD), which could become permanent
• If you have diabetes or have risk factors or symptoms of diabetes, your blood sugar should be
monitored. High blood sugar has been reported with ABILIFY and medicines like it. In some cases,
extreme high blood sugar can lead to coma or death
• Other risks may include lightheadedness upon standing, decreases in white blood cells (which can be
serious), seizures, trouble swallowing, or impairment in judgment or motor skills. Until you know
how ABILIFY affects you, you should not drive or operate machinery
The common side effects in adults in clinical trials ( >
10
% ) include nausea, vomiting, constipation,
headache, dizziness, an inner sense of restlessness or need to move (akathisia), anxiety, and insomnia.
Tell your doctor about all the medicines you’re taking, since there are some risks for drug interactions.
You should avoid alcohol while taking ABILIFY.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call
1
-
800
-F D A -
1088
.
Please read the Important Information about ABILIFY on the adjacent page.
•Lexapro® (escitalopram oxalate), Zoloft® (sertraline HCI), Prozac® (fluoxetine hydrochloride), Effexor XR® (venlafaxine HCI),
Paxil CR® (paroxetine HCI) are trademarks of their respective companies.
Bristol-Myers Squibb
^ O t s u k a
otsuka America Pharmaceutical, inc.
©2009 Otsuka America Pharmaceutical. Inc., Rockville. MD
570US09A829302
June 2009
0309A-2306
Printed in USA
A B I L I F Y
(aripiprazole)
2
m g,
5
m g T ab le t
IF A N A N T ID E P R E S S A N T
A L O N E IS N 'T E N O U G H .
www.abilifytreatment.com
If you Of «m«no you know iwdi hHp paying to« meJkii*. ul
1-S83-WA-NOW (I-833^77-2669). Or
9010
wwwpp#J<X
9
Partnership for
v y ' '
Prescription Assistance
previous page 262 Better Homes And Gardens 2009 10 read online next page 264 Better Homes And Gardens 2009 10 read online Home Toggle text on/off